Mark J. Murray
ZymoGenetics
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mark J. Murray.
Growth Factors Journal | 1991
Yasushi Ogawa; George A. Ksander; Bruce M. Pratt; Steven J. Sawamura; Jill M. Ziman; Carolyn O. Gerhardt; Paula D. Avis; Mark J. Murray; John M. McPherson
Transforming growth factor-beta 1 (TGF-beta 1 and recombinant platelet-derived growth factor-BB (rPDGF-BB) promoted an extensive, dose-dependent development of fibrous connective tissue when continuously delivered for 8 days by mini-osmotic pumps implanted subcutaneously in adult guinea pigs. Biochemical analyses demonstrated that TGF-beta 1 and rPDGF-BB stimulated dose-dependent increases in the dry weight, and protein, DNA, collagen, and glycosaminoglycan (GAG) contents of the fibrous connective tissue capsule that enveloped the pumps. The GAG/DNA mass ratio was markedly elevated by TGF-beta 1, but the collagen/DNA, protein/DNA, and collagen/protein ratios were not significantly increased. In contrast, rPDGF-BB generally decreased these mass ratios. Histological analyses suggested that this was due to the fact that rPDGF-BB induced a very cellular response with a marked influx of neutrophils and fibroblasts. TGF-beta 1 induced significantly less cellular response, which consisted primarily fibroblasts and macrophages. These results indicated that rPDGF-BB and TGF-beta 1 induced connective tissue deposition in vivo in a dose-dependent fashion, although the cellular nature of the responses as well as the structural composition of the extracellular matrices were clearly distinguishable between the two growth factors.
Growth Factors Journal | 1990
Huseyin Mehmet; Eewa Nånberg; Wolfram Lehmann; Mark J. Murray; Enrique Rozengurt
Platelet-derived growth factor (PDGF) occurs as three dimeric isoforms, AA, BB, and AB. Two distinct receptor subunits, alpha and beta, have been identified which bind either all three isoforms of PDGF (alpha) or PDGF-BB only (beta). Here, we have compared the effect of purified PDGF homodimers on the early intracellular signaling events and mitogenesis in Swiss 3T3 cells, which possess equivalent numbers of the alpha and beta subunits. Both PDGF-AA and PDGF-BB stimulated receptor phosphorylation, inositol phosphate formation, activation of protein kinase C, calcium mobilization, EGF receptor transmodulation, sodium uptake, arachidonic acid release, cyclic AMP accumulation, and c-fos induction in a comparable, dose-dependent manner (half-maximal values for all these response were in the 2-10 ng/ml range for both homodimers). At high concentrations of PDGF (greater than 10 ng/ml), the BB homodimer effect on early membrane and cytosolic signals was 20-30% greater than PDGF-AA, reflecting the greater number of available binding sites for PDGF-BB. DNA synthesis studies indicated that PDGF-AA and PDGF-BB were potent mitogens for Swiss 3T3 cells, displaying identical dose-response effects. Moreover, the mitogenic activities of both homodimers were equally potentiated in the presence of insulin. These results indicate that both PDGF-AA and PDGF-BB stimulate the full complement of molecular responses required for the synergistic interactions mediating long-term mitogenesis. We conclude that alpha and beta receptor subunits do not differ in their ability to transduce PDGF-mediated signals leading to DNA synthesis in Swiss 3T3 cells.
American Journal of Pathology | 1990
David G. Greenhalgh; Katherine H. Sprugel; Mark J. Murray; Russell Ross
Archive | 1986
Frederick S. Hagen; Mark J. Murray; Sharon J. Busby; Kathleen L. Berkner; Margaret Y. Insley; Richard G Woodbury; Charles L Gray
Archive | 1986
Mark J. Murray; James D. Kelly
Archive | 1988
Mark J. Murray; James D. Kelly
Archive | 1987
Donald C. Foster; Mark J. Murray; Kathleen L. Berkner
Archive | 1988
Mark J. Murray; James D. Kelly
Archive | 1994
Donald C. Foster; Mark J. Murray; Kathleen L. Berkner
Archive | 1992
Mark J. Murray; James D. Kelly